Primary lymphedema is due to abnormal congenital development or dysfunction in the lymphatic system. Limited data exist on the prevalence of primary lymphedema and there are only few studies focusing on primary lymphedema. The purpose of this article is to review the current options for surgical treatment of primary lymphedema.
Get full access to this article
View all access options for this article.
References
1.
LeeBB, LaredoJ, LeeTS, HuhS, NevilleR. Terminology and classification of congenital vascular malformations. Phlebology, 2007; 22:249–252.
2.
RocksonSG, RiveraKK. Estimating the population burden of lymphedema. Ann N Y Acad Sci, 2008; 1131:147–154.
3.
MaclellanRA, CoutoRA, SullivanJE, GrantFD, SlavinSA, GreeneAK. Management of primary and secondary lymphedema: Analysis of 225 referrals to a center. Ann Plast Surg, 2015; 75:197–200.
4.
WolfeJN, KinmonthJB. THe prognosis of primary lymphedema of the lower limbs. Arch Surg, 1981; 116:1157–1160.
5.
SmeltzerDM, SticklerGB, SchirgerA. Primary lymphedema in children and adolescents: A follow-up study and review. Pediatrics, 1985; 76:206–218.
6.
van der WaltJC, PerksTJ, Bruce-ChwattAJ, GraeweFR. Modified Charles procedure using negative pressure dressings for primary lymphedema: A functional assessment. Ann Plast Surg, 2009; 62:669–675.
7.
LeeB, AndradeM, BerganJ, BoccardoF, CampisiC, DamstraR, FlourM, GloviczkiP, LaredoJ, PillerN, MicheliniS, MortimerP, VillavicencioJL. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol, 2010; 29:454–470.
8.
DemirtasY, OzturkN, YapiciO, TopalanM. Comparison of primary and secondary lower-extremity lymphedema treated with supermicrosurgical lymphaticovenous anastomosis and lymphaticovenous implantation. J Reconstr Microsurg, 2010; 26:137–143.
HaraH, MiharaM, OhtsuH, NarushimaM, IidaT, KoshimaI. Indication of lymphaticovenous anastomosis for lower limb primary lymphedema. Plast Reconstr Surg, 2015; 136:883–893.
11.
DaleRF. The inheritance of primary lymphoedema. J Med Genet, 1985; 22:274–278.
12.
MurdacaG, CagnatiP, GulliR, SpanoF, PuppoF, CampisiC, BoccardoF. Current views on diagnostic approach and treatment of lymphedema. Am J Med, 2012; 125:134–140.
13.
LeeB, LaredoJ, NevilleR. Reconstructive surgery for chronic lymphedema: A viable option, but. Vascular, 2011; 19:195–205.
14.
SchookCC, MullikenJB, FishmanSJ, GrantFD, ZurakowskiD, GreeneAK. Primary lymphedema: Clinical features and management in 138 pediatric patients. Plast Reconstr Surg, 2011; 127:2419–2431.
15.
ConnellFC, GordonK, BriceG, KeeleyV, JefferyS, MortimerPS, MansourS, OstergaardP. The classification and diagnostic algorithm for primary lymphatic dysplasia: An update from 2010 to include molecular findings. Clin Genet, 2013; 84:303–314.
KerchnerK, FleischerA, YosipovitchG. Lower extremity lymphedema: Update: Pathophysiology, diagnosis, and treatment guidelines. J Am Acad Dermatol, 2008; 59:324–331.
18.
ElyJW, OsheroffJA, ChamblissML, EbellMH. Approach to leg edema of unclear etiology. J Am Board Fam Med, 2006; 19:148–160.
19.
TiwariA, ChengKS, ButtonM, MyintF, HamiltonG. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg, 2003; 138:152–161.
20.
LeeBB, AndradeM, AntignaniPL, BoccardoF, BunkeN, CampisiC, DamstraR, FlourM, Forner-CorderoI, GloviczkiP, LaredoJ, PartschH, PillerN, MicheliniS, MortimerP, RabeE, RocksonS, ScuderiA, SzolnokyG, VillavicencioJL. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol, 2013; 32:541–574.
21.
GloviczkiP, CalcagnoD, SchirgerA, PairoleroPC, CherryKJ, HallettJW, WahnerHW. Noninvasive evaluation of the swollen extremity: Experiences with 190 lymphoscintigraphic examinations. J Vasc Surg, 1989; 9:683–689; discussion 690.
22.
BelliniC, BoccardoF, CampisiC, VillaG, TaddeiG, TraggiaiC, BonioliE. Lymphatic dysplasias in newborns and children: The role of lymphoscintigraphy. J Pediatr, 2008; 152:587–589, 589.e581–e583.
MaegawaJ, MikamiT, YamamotoY, SatakeT, KobayashiS. Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis. Microsurgery, 2010; 30:437–442.
25.
YamamotoT, MatsudaN, DoiK, OshimaA, YoshimatsuH, TodokoroT, OgataF, MiharaM, NarushimaM, IidaT, KoshimaI. The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: The modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg, 2011; 128:314e–321e.
26.
YamamotoT, NarushimaM, DoiK, OshimaA, OgataF, MiharaM, KoshimaI, MundingerGS. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: The generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg, 2011; 127:1979–1986.
27.
AkitaS, MitsukawaN, RikihisaN, KubotaY, OmoriN, MitsuhashiA, TateS, ShozuM, SatohK. Early diagnosis and risk factors for lymphedema following lymph node dissection for gynecologic cancer. Plast Reconstr Surg, 2013; 131:283–290.
28.
YamamotoT, YoshimatsuH, NarushimaM, YamamotoN, HayashiA, KoshimaI. Indocyanine green lymphography findings in primary leg lymphedema. Eur J Vasc Endovasc Surg, 2015; 49:95–102.
29.
PeckingAP, WartskiM, CluzanRV, BelletD, AlberiniJL. SPECT-CT fusion imaging radionuclide lymphoscintigraphy: Potential for limb lymphedema assessment and sentinel node detection in breast cancer. Cancer Treat Res, 2007; 135:79–84.
30.
BlumKS, RadtkeC, KnappWH, PabstR, GratzKF. SPECT-CT: A valuable method to document the regeneration of lymphatics and autotransplanted lymph node fragments. Eur J Nucl Med Mol Imaging, 2007; 34:1861–1867.
31.
LiuN, ZhangY. Magnetic resonance lymphangiography for the study of lymphatic system in lymphedema. J Reconstr Microsurg, 2016; 32:66–71.
32.
BorriM, SchmidtMA, GordonKD, WallaceTA, HughesJC, ScurrED, KohDM, LeachMO, MortimerPS. Quantitative contrast-enhanced magnetic resonance lymphangiography of the upper limbs in breast cancer related lymphedema: An exploratory study. Lymphat Res Biol, 2015; 13:100–106.
33.
MortimerP. Investigation and management of lymphoedema. Vasc Med, 1990; 1:1–20.
KoDS, LernerR, KloseG, CosimiAB. Effective treatment of lymphedema of the extremities. Arch Surg, 1998; 133:452–458.
37.
FöldiE. The treatment of lymphedema. Cancer, 1998; 83:2833–2834.
38.
JohnstoneP, HawkinsK, HoodS. Role of patient adherence in maintenance of results after manipulative therapy for lymphedema. J Soc Integr Oncol, 2005; 4:125–129.
39.
O'BrienJG, ChennubhotlaSA, ChennubhotlaRV. Treatment of edema. Am Fam Physician, 2005; 71:2111–2117.
40.
CemalY, PusicA, MehraraBJ. Preventative measures for lymphedema: Separating fact from fiction. J Am Coll Surg, 2011; 213:543.
41.
BrennanMJ, MillerLT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer, 1998; 83:2821–2827.
42.
AndrejakM, GersbergM, SgroC, DecocqG, HamelJD, MorinM, GrasV. French pharmacovigilance survey evaluating the hepatic toxicity of coumarin. Pharmacoepidemiol Drug Saf, 1998; 7Suppl 1:S45–S50.
43.
NakamuraK, RadhakrishnanK, WongYM, RocksonSG. Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One, 2009; 4:e8380.
44.
MortimerPS, RocksonSG. New developments in clinical aspects of lymphatic disease. J Clin Invest, 2014; 124:915–921.
45.
JinDP, AnA, LiuJ, NakamuraK, RocksonSG. Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: Immunohistochemical and molecular characterization. Lymphat Res Biol, 2009; 7:47–57.
46.
AkgulA, CirakM, BirinciT. Applications of platelet-rich plasma in lymphedema. Lymphat Res Biol, 2016; 14:206–209.
47.
MehraraBJ, ZampellJC, SuamiH, ChangDW. Surgical management of lymphedema: Past, present, and future. Lymphat Res Biol, 2011; 9:159–167.
48.
ChangDW, MasiaJ, GarzaR3rd, SkorackiR, NeliganPC. Lymphedema: Surgical and medical therapy. Plast Reconstr Surg, 2016; 138:209s–218s.
49.
CharlesH. Elephantiasis Scroti. In: LathamA, EnglishTC, editors. A system of treatment. Vol 3. Calcutta: Butterworth & Co (India) Ltd; 1912. pp. 511–516.
50.
MillerTA, WyattLE, RudkinGH. Staged skin and subcutaneous excision for lymphedema: A favorable report of long-term results. Plast Reconstr Surg, 1998; 102:1486–1498; discussion 1499–1501.
ChangDW, SuamiH, SkorackiR. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg, 2013; 132:1305–1314.
59.
MiharaM, HaraH, TangeS, ZhouHP, KawaharaM, ShimizuY, MuraiN. Multisite lymphaticovenular bypass using supermicrosurgery technique for lymphedema management in lower lymphedema cases. Plast Reconstr Surg, 2016; 138:262–272.
60.
BastaMN, GaoLL, WuLC. Operative treatment of peripheral lymphedema: A systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg, 2014; 133:905–913.
61.
O'BrienBM, MellowCG, KhazanchiRK, DvirE, KumarV, PedersonWC. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg, 1990; 85:562–572.
62.
TashiroK, YamashitaS, SaitoT, IidaT, KoshimaI. Proximal and distal patterns: Different spreading patterns of indocyanine green lymphography in secondary lower extremity lymphedema. J Plast Reconstr Aesthet Surg, 2016; 69:368–375.
63.
RajuA, ChangDW. Vascularized lymph node transfer for treatment of lymphedema: A comprehensive literature review. Ann Surg, 2015; 261:1013–1023.
64.
TouraniSS, TaylorGI, AshtonMW. Vascularized Lymph Node Transfer: A review of the current evidence. Plast Reconstr Surg, 2016; 137:985–993.
65.
ChengMH, ChenSC, HenrySL, TanBK, LinMC, HuangJJ. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: Flap anatomy, recipient sites, and outcomes. Plast Reconstr Surg, 2013; 131:1286–1298.
